";s:4:"text";s:3708:" Mirabegron has not been studied in patients with severe hepatic impairment (Child-Pugh Class C).Mirabegron is transported and metabolized through multiple pathways. In the event of overdosage, pulse rate, blood pressure and ECG monitoring is recommended.In a study of 352 healthy subjects assessing the effect of multiple daily doses of 50 mg, 100 mg, and 200 mg of MYRBETRIQIn another study in 96 healthy subjects to assess the impact of age on pharmacokinetics of multiple daily doses of 50 mg, 100 mg, 200 mg, and 300 mg of MYRBETRIQIn three, 12-week, double-blind, placebo-controlled, safety and efficacy studies (Studies 1, 2 and 3) in OAB patients receiving MYRBETRIQAfter oral administration of mirabegron in healthy volunteers, mirabegron is absorbed to reach maximum plasma concentrations (Cmax) at approximately 3.5 hours. You may report side effects to Health Canada at 1-866-234-2345.If someone has overdosed and has serious symptoms such as passing out or If you miss a dose, take it as soon as you remember. Common side effects of Myrbetriq include headache, increased blood pressure, constipation, dizziness, diarrhea, back pain, dry mouth, joint pressure, and common cold symptoms. If it is near the time of the next dose, skip the missed dose. It is practically insoluble in water (0.082 mg/mL). The volume of distribution at steady state (Vss) is approximately 1670 L following intravenous administration. The majority of these patients had pre-existing medical conditions or concomitant medications that may cause confusion, hallucinations, insomnia and anxiety. Do not double the dose to catch up.Store at room temperature away from light and moisture. After once daily administration, plasma exposure of mirabegron at steady state is approximately double that seen after a single dose.Co-administration of a 50 mg tablet with a high-fat meal reduced mirabegron Cmax and AUC by 45% and 17%, respectively. If you notice other effects not listed above, contact your doctor or pharmacist.Call your doctor for medical advice about side effects. Reversible adverse developmental findings consisting of delayed In the rat embryo/fetal developmental toxicity study, pregnant rats received daily oral doses of mirabegron at 0, 10, 30, 100, or 300 mg/kg from In the rabbit embryo/fetal developmental toxicity study, pregnant rabbits received daily oral doses of mirabegron at 0, 3, 10, or 30 mg/kg from implantation to closure of the fetal hard No dose adjustment is necessary for the elderly. Consult your doctor before taking Myrbetriq if pregnant or breastfeeding. INDICATIONS. MYRBETRIQ ® 25 mg is effective within 8 weeks. The recommended starting dose of MYRBETRIQ ® is 25 mg once daily with or without food. Prices are for cash paying customers only and are not valid with insurance plans.